| URL | https://www.bullrunnow.com/news/article/18.5_milli |
| Source | Bull Run Now |
| Date Published | 07/19/2024 |
| Company/Division name | Capra Biosciences |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Year reshoring announced: | 2024 |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 7.5 |
| State(s) reshored to: | VA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | active pharmaceutical ingredients |
| What domestic positive factors made reshoring more attractive? | Government Incentives |